Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "London Diabetes Conference Mar 2012"

19:52 EDT 24th April 2014 | BioPortfolio

Matching Channels

Matching News

Diabetes, pre-diabetes, gestational diabetes increasing among privately insured Americans

About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending o...

Diabetes most common among older men and those living in the South

About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending o...

New report shows diagnosed diabetes, pre-diabetes, and gestational diabetes is on the rise among privately insured Ameri

About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending o...

New report shows diagnosed diabetes, pre-diabetes, and gestational diabetes is on the rise among privately insured Americans

(Burness Communications) About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of d...

Diagnosed diabetes, pre-diabetes, and gestational diabetes on the rise among privately insured Americans

About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending o...

Novo Nordisk launches diabetes collaboration focused on integrated care with London partners

A unique collaboration between leading London hospitals and Danish insulin giant Novo Nordisk (NOV: N) launched the i3-diabetes program today, which aims to put people with diabetes at the center of t...

UCL and Novo Nordisk partner to take action against urban diabetes

(University College London) UCL is partnering with Novo Nordisk and the Steno Diabetes Center -- a world leading institution in diabetes care and prevention -- to launch the Cities Changing Diabetes i...

8th Annual Parallel Trade Conference, 10th and 11th February 2014, London

SMi invites you to its 8th annual Parallel Trade conference, taking place in London on the 10th and 11th February 2014. We are very grateful to our Chairman, Dr Eric Noehrenberg, Director Public Affai...

Matching PubMed Articles

Considerations in the design of randomized trials to screen for type 2 diabetes.

Randomized controlled trials (RCTs) are the most robust and valid approach to evaluate screening for diseases. Many in the diabetes research community have advocated sole reliance on RCTs for designin...

Management of diabetes in palliative care.

Of the half a million people who die in the United Kingdom each year, approximately 6-9% will have Diabetes Mellitus (DM). The 2011 position statement regarding diabetes management at the end of life...

Update of Retraction--Blockade of Receptor for Advanced Glycation End Products in a Model of Type 1 Diabetic Leukoencephalopathy. Diabetes. 19 November 2012 Epub ahead of print. DOI: 10.2337/db12-0317.

Conference calendar.

Conference calendar.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement